Join GSK, Boehringer Ingelheim, Novo Nordisk, Genzyme, Baxter AG & many more at Lyophilisation 2014

LONDON - June 11, 2014 - PRLog -- Biologics like proteins, vaccines and other injectables must remain effective from manufacture to patient administration. Lyophilisation is one of the most effective ways of giving to biotechnologically produced drugs greater stability and a longer shelf-life, while still maintaining their effectiveness.For drug manufacturers, the challenge may at first appear daunting, but it is one that must be met if the compounds being developed are to be successful.

Just 4 weeks away until SMi opens its doors to the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on best practices in lyophilisation and examine the latest techniques and industry case studies.With a workshop and sessions led by experts, you will gain an array of tools and tips to deliver the best outcome for your organisation.

Benefits of Attending
•  Using vibrational spectroscopic measurements during pharmaceutical freeze-drying
•  Key presentation from MedImmune on advancements in Lyophilised Drug Product Development and Scale-Up
•  Discuss using Lyophilisation kinetics using freeze drying microscopy
•  Hear more about mathematical modelling in freeze drying
•  Case study from GSK on their 3-stage validation approach for lyophilised products
•  Evaluate lyophilisation optimisation and validation featuring Ipsen

Hear from Key Speakers Including:
•  Andrea Weiland, CEO, Explicat Pharma
•  Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline
•  Jason Gray, Consultant, Allembis (ex-Merck)
•  Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen
•  Sune Andersen, Principal Scientist, Novo Nordisk
•  Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim
•  Sean Cullen, Development Scientist, Genzyme Ireland in collaboration with University College Cork
•  Jamie Biddlecombe, Scientist II, Formulation Sciences, MedImmune
•  Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University
•  Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College London

For those who are interested in attending there is currently a £200 reduced offer if you book online with the following discount code: SMI4K3E

A snapshot of attendees this year: Boehringer Ingelheim, Allembis, Norgine, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Ellab, Ipsen, Baxter AG, Ghent University, Genzyme Ireland, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London, Chr. Hansen, LFB Technologies, SP Scientific, University of Sao Paulo, plus more...

For more information please visit:
Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK
http://www.smi-online.co.uk/2014lyophilisation52.asp (http://www.smi-online.co.uk/2014lyophilisation61.asp)